#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Internal Medicine - Issue 7/2022

Editorial

415

Hlavní téma – Nefrologie

Main Topic

420

Current options for slowing the progression of chronic kidney disease

Vladimír Tesař

426

Expert opinion on the cooperation of diabetologists and internists with nephrologists in the care of patients with chronic kidney diseases

Ondřej Viklický, Romana Ryšavá, Vladimír Tesař, Ivan Rychlík, Martin Prázný, Richard Češka, Martin Haluzík

432

Glomerulonephritides associated with infections

Martin Havrda

438

New developments in anaemia treatment – erythropoietin versus prolyl hydroxylase inhibitors?

Romana Ryšavá

444

Covid-19 in kidney transplant recipients

Mária Magicová, Ondřej Viklický

Review Articles

449

Reactive, infectious, or post‑infectious arthritis?

Štefan Alušík

Case reports

454

Effect of SGLT2 inhibitor empagliflozin on the stabilization of heart failure progress with the possibility of further interventions in a patient with HFrEF – a case report

Filip Málek

458

New technology in the hypolipidemic drugs development. Inclisiran (LEQVIO)

Hana Rosolová

461

Therapy of hypertension in elderly population and its potential risks

Jiří Widimský

In Brief

465

Thyroid incidentalomas

Jan Jiskra

Advertorial

475

Můžeme novou léčbou ovlivnit dosavadní terapií neřešený zánět a fibrózu u pacientů s DM2 a CKD?

Milan Kvapil

Internal Medicine

Issue 7

2022 Issue 7

Most read in this issue

#ADS_BOTTOM_SCRIPTS#